| Financial Year |
March 31 2023 |
| Monetary Funds |
945,288,379.20 |
| Held-for-trading Financial Assets |
300,000,000.00 |
| Notes Receivable |
15,953,550.57 |
| Accounts Receivable |
985,786,171.35 |
| Advances to Suppliers |
11,938,114.50 |
| Other Receivables |
24,574,547.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
282,658,086.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
257,849,567.44 |
| Other Current Assets |
5,073,743.93 |
| Total Current Assets |
3,173,391,910.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
26,298,213.75 |
| Long-term Equity Investment |
12,495,579.09 |
| Investment Properties |
85,794,621.36 |
| Fixed Assetes |
378,533,278.45 |
| Under-construction Projects |
20,818,108.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
246,768,961.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,148,122.41 |
| Deferred Income Tax Assets |
138,627,851.51 |
| Other Non-Current Assets |
11,597,528.39 |
| Sub-Total of Non-Current Assets |
1,359,147,382.52 |
| Total Assets |
4,532,539,292.80 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
331,889,589.20 |
| Accounts Payable |
547,577,130.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
208,550,083.28 |
| Taxes Payable |
109,197,308.85 |
| Interest Payable |
-- |
| Dividend Payable |
1,830,852.80 |
| Other payables |
270,529,245.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
381,712.71 |
| Other Current Liabilities |
41,359,112.57 |
| Sub-Total of Current Liabilities |
1,567,409,315.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,040,083.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
153,391,590.77 |
| Deferred Income Tax Liabilities |
87,895,194.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
304,554,000.46 |
| Total Liabilities |
1,871,963,315.88 |
| Paid-In Capital(Or Share Stock) |
546,180,037.00 |
| Capital Surplus |
1,051,833,413.84 |
| Surplus Reserve |
299,245,514.10 |
| LESS:Treasury Stock |
161,974,621.20 |
| Undistributed Profits |
693,646,009.78 |
| Minority Stockholder's Interest |
199,764,667.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,460,811,309.73 |
| Owner's Equity（Stockholder's Equity） |
2,660,575,976.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,532,539,292.80 |
